(OTLK) Outlook Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Outlook Therapeutics | (OTLK) share price targets
Complete technical analysis of Outlook Therapeutics (OTLK) by charts plus indicators, forecast predictions and share price targets for Outlook Therapeutics (OTLK)
Outlook Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-24 View latest technical analysis
10 day averaged volume of Outlook Therapeutics is 227490
Date | Daily Closing Price | Open | High | Low | Volume |
24 Mon Jun 2024 | 7.43 | 7.63 | 7.95 | 7.42 | 1.029 times |
21 Fri Jun 2024 | 7.63 | 7.72 | 7.72 | 7.37 | 3.611 times |
20 Thu Jun 2024 | 7.59 | 7.25 | 7.67 | 7.23 | 0.759 times |
18 Tue Jun 2024 | 7.07 | 7.58 | 7.84 | 7.05 | 0.704 times |
18 Tue Jun 2024 | 7.07 | 7.58 | 7.84 | 7.05 | 0.704 times |
17 Mon Jun 2024 | 7.56 | 7.58 | 7.90 | 7.51 | 0.455 times |
14 Fri Jun 2024 | 7.67 | 7.67 | 7.96 | 7.57 | 0.497 times |
13 Thu Jun 2024 | 7.66 | 7.55 | 7.75 | 7.53 | 0.422 times |
12 Wed Jun 2024 | 7.55 | 7.85 | 8.00 | 7.44 | 0.817 times |
11 Tue Jun 2024 | 7.63 | 7.07 | 7.65 | 7.07 | 0.865 times |
My analysis of stock is bullish for shortterm, and stock might move up till 7.6 or till 8. Use a stoploss of 7.33 and if this stock hits its stoploss, then it can fall down till 7.03
Share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Target | 0.31 |
Downside Target | 0.35 |
Downside Target | 0.50 |
Downside Target | 6.65 |
Downside Target | 6.80 |
Downside Target | 7.05 |
Downside Target | 7.42 |
Upside Target | 7.80 |
Upside Target | 7.95 |
Upside Target | 8.00 |
Upside Target | 9.12 |
Upside Target | 12.70 |
Upside Target | 12.85 |
Intraday share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Intraday Target | 7.25 |
Downside Intraday Target | 7.07 |
Upside Intraday Target | 7.78 |
Upside Intraday Target | 8.13 |
Upside Intraday Target | 7.6 |
Weekly technical analysis of Outlook Therapeutics (OTLK)
Date | Weekly Closing Price | Open | High | Low | Volume |
24 Mon Jun 2024 | 7.43 | 7.63 | 7.95 | 7.42 | 0.203 times |
21 Fri Jun 2024 | 7.63 | 7.58 | 7.84 | 7.05 | 4.377 times |
18 Tue Jun 2024 | 7.07 | 7.58 | 7.90 | 7.05 | 0.308 times |
14 Fri Jun 2024 | 7.67 | 6.69 | 8.00 | 6.66 | 0.877 times |
07 Fri Jun 2024 | 6.79 | 7.07 | 7.49 | 6.65 | 0.741 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Outlook Therapeutics (OTLK)
Date | Monthly Closing Price | Open | High | Low | Volume |
24 Mon Jun 2024 | 7.43 | 7.07 | 8.00 | 6.65 | 0.605 times |
31 Fri May 2024 | 7.07 | 8.93 | 9.12 | 6.80 | 0.678 times |
30 Tue Apr 2024 | 8.92 | 12.36 | 12.85 | 7.80 | 0.184 times |
28 Thu Mar 2024 | 11.94 | 0.44 | 12.70 | 0.31 | 1.494 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Outlook Therapeutics (OTLK)
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term and the buy signal is strong.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Outlook Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.52 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term and the buy signal is strong.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Outlook Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.52 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.